Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

• Ammar Abdulrahman Jairoun,
• Sabaa Saleh Al-Hemyari,
• Moyad Shahwan,
• Tariq Al-Qirim,
• Monzer Shahwan

Affiliations

Ammar Abdulrahman Jairoun

Health and Safety Department, Dubai Municipality, Dubai, UAE

Sabaa Saleh Al-Hemyari

Pharmacy Department, Emirates Health Services, Dubai, UAE

Moyad Shahwan

Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, UAE

Tariq Al-Qirim

Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan

Monzer Shahwan

Diabetes Clinic, AL-Swity Center for Dermatology and Chronic Diseases, Ramallah, Palestine